Nancy Lurker
Chief Executive Officer, INTERPACE BIOSCIENCES, INC.
Companies
- COLLEGIUM PHARMACEUTICAL, INCBoard member Feb 5, 2025 to now1
- AlkermesBoard member Mar 15, 2024 to now2
- EyePoint PharmaceuticalsBoard member Dec 14, 2016 to now3
- EyePoint PharmaceuticalsOfficer Feb 11, 2021 to Jul 12, 20244
- EyePoint PharmaceuticalsChief executive officer Sep 20, 2016 to Jun 22, 20235
- EyePoint PharmaceuticalsPresident Sep 20, 2016 to Mar 2, 20225
- Aquestive Therapeutics, Inc.Board member Jul 24, 2018 to Jun 17, 20216
- Keenova Therapeutics plcBoard member Jul 2, 2013 to Mar 18, 20167
- INTERPACE BIOSCIENCES, INC.Board member Nov 7, 2014 to Mar 9, 20158
- INTERPACE BIOSCIENCES, INC.Chief executive officer Nov 24, 2008 to Mar 9, 20159
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- EyePoint Pharmaceuticals EYPT421,235 shares10$1.3M at $2.99Jan 7, 2026
- COLLEGIUM PHARMACEUTICAL, INC COLL26,758 shares11$620.5K at $23.19May 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2026Shares withheld for tax 1,475 shares at $36.95 of CIK 152026212
- May 21, 2026Exercised options 6,142 shares of CIK 152026212
- May 14, 2026Granted 8,741 shares of COLLEGIUM PHARMACEUTICAL, INC11
- May 13, 2026Sold 4,500 shares at $35.97 of COLLEGIUM PHARMACEUTICAL, INC13
- Apr 11, 2026Shares withheld for tax 901 shares at $33.36 of CIK 152026214
- Apr 11, 2026Exercised options 3,751 shares of CIK 152026214
- Jan 6, 2026Exercised options 75,133 shares of EyePoint Pharmaceuticals10
- Jan 5, 2026Exercised options 12,666 shares of EyePoint Pharmaceuticals15
- Dec 4, 2025Sold 9,300 shares at $15.11 of EyePoint Pharmaceuticals16
- Nov 28, 2025Sold 500 shares at $14.95 of EyePoint Pharmaceuticals17
- Nov 26, 2025Sold 200 shares at $14.95 of EyePoint Pharmaceuticals17
- Jul 10, 2025Exercised options 11,111 shares of EyePoint Pharmaceuticals18
- May 31, 2025Shares withheld for tax 1,924 shares at $30.61 of CIK 152026219
- May 31, 2025Exercised options 8,013 shares of CIK 152026219
- May 15, 2025Granted 9,791 shares of COLLEGIUM PHARMACEUTICAL, INC20
- Apr 11, 2025Shares withheld for tax 901 shares at $27.00 of CIK 152026221
- Apr 11, 2025Exercised options 3,752 shares of CIK 152026221
- Apr 11, 2025Shares withheld for tax 558 shares at $27.00 of CIK 152026221
- Apr 11, 2025Exercised options 2,323 shares of CIK 152026221
- Feb 9, 2025Exercised options 20,000 shares of EyePoint Pharmaceuticals22
- Feb 4, 2025Granted 12,726 shares of COLLEGIUM PHARMACEUTICAL, INC23
- Jan 6, 2025Exercised options 75,134 shares of EyePoint Pharmaceuticals24
- Jan 5, 2025Exercised options 12,667 shares of EyePoint Pharmaceuticals24
- Aug 16, 2024Bought 3,173 shares at $7.88 of EyePoint Pharmaceuticals25
- Jul 10, 2024Exercised options 11,111 shares of EyePoint Pharmaceuticals26
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAlkermes, Board member
- 3
- 4SEC EDGAREyePoint Pharmaceuticals, Officer
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed May 22, 2026
- 13SEC EDGARForm 4 filed May 15, 2026
- 14SEC EDGARForm 4 filed Apr 13, 2026
- 15SEC EDGARForm 4 filed Jan 6, 2026
- 16SEC EDGARForm 4 filed Dec 5, 2025
- 17SEC EDGARForm 4 filed Dec 1, 2025
- 18SEC EDGARForm 4 filed Jul 11, 2025
- 19SEC EDGARForm 4 filed Jun 2, 2025
- 20SEC EDGARForm 4 filed May 19, 2025
- 21SEC EDGARForm 4 filed Apr 14, 2025
- 22SEC EDGARForm 4 filed Feb 11, 2025
- 23SEC EDGARForm 4 filed Feb 5, 2025
- 24SEC EDGARForm 4 filed Jan 7, 2025
- 25SEC EDGARForm 4 filed Aug 20, 2024
- 26SEC EDGARForm 4 filed Jul 12, 2024